RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Isofol Medical AB (publ) Stock

Isofol Medical AB (publ) ROCE 2024

Isofol Medical AB (publ) ROCE

-0.34

Ticker

ISOFOL.ST

ISIN

SE0009581051

WKN

A2DPV6

In 2024, Isofol Medical AB (publ)'s return on capital employed (ROCE) was -0.34, a -67.53% increase from the -1.06 ROCE in the previous year.

Isofol Medical AB (publ) Aktienanalyse

What does Isofol Medical AB (publ) do?

Isofol Medical AB (publ) is a Swedish company that was founded in 2006 and is listed on the Nasdaq Stockholm exchange. The company focuses on the development of medical solutions for a wide range of diseases, with a particular emphasis on cancer treatment. Isofol's main product is Modufolin, a proprietary technology that is an advancement of the well-known drug Folic Acid, commonly used in cancer therapy. Modufolin has a longer duration in the body, making it more effective in inhibiting tumor cell growth. Isofol also has a diagnostic division that specializes in developing tests for detecting Vitamin B12 levels in the body, which are crucial for identifying diseases such as dementia and anemia. Isofol Medical AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Isofol Medical AB (publ)'s Return on Capital Employed (ROCE)

Isofol Medical AB (publ)'s Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Isofol Medical AB (publ)'s ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Isofol Medical AB (publ)'s ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Isofol Medical AB (publ)’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Isofol Medical AB (publ) stock

What is the ROCE (Return on Capital Employed) of Isofol Medical AB (publ) this year?

The ROCE of Isofol Medical AB (publ) is -0.34 undefined this year.

How has the ROCE (Return on Capital Employed) of Isofol Medical AB (publ) developed compared to the previous year?

The ROCE of Isofol Medical AB (publ) has increased by -67.53% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Isofol Medical AB (publ)?

A high Return on Capital Employed (ROCE) indicates that Isofol Medical AB (publ) has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Isofol Medical AB (publ)?

A low ROCE (Return on Capital Employed) can indicate that Isofol Medical AB (publ) has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Isofol Medical AB (publ) impact the company?

An increase in the ROCE of Isofol Medical AB (publ) can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Isofol Medical AB (publ) affect the company?

A decrease in ROCE of Isofol Medical AB (publ) can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Isofol Medical AB (publ)?

Some factors that can affect Isofol Medical AB (publ)'s ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Isofol Medical AB (publ) so important for investors?

The ROCE of Isofol Medical AB (publ) is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Isofol Medical AB (publ) take to improve the ROCE?

To improve the ROCE, Isofol Medical AB (publ) can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Isofol Medical AB (publ) pay?

Over the past 12 months, Isofol Medical AB (publ) paid a dividend of 0.76 SEK . This corresponds to a dividend yield of about 33.57 %. For the coming 12 months, Isofol Medical AB (publ) is expected to pay a dividend of 0.76 SEK.

What is the dividend yield of Isofol Medical AB (publ)?

The current dividend yield of Isofol Medical AB (publ) is 33.57 %.

When does Isofol Medical AB (publ) pay dividends?

Isofol Medical AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Isofol Medical AB (publ)?

Isofol Medical AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Isofol Medical AB (publ)?

For the upcoming 12 months, dividends amounting to 0.76 SEK are expected. This corresponds to a dividend yield of 33.57 %.

In which sector is Isofol Medical AB (publ) located?

Isofol Medical AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Isofol Medical AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Isofol Medical AB (publ) from 2/20/2023 amounting to 0.755 SEK, you needed to have the stock in your portfolio before the ex-date on 2/14/2023.

When did Isofol Medical AB (publ) pay the last dividend?

The last dividend was paid out on 2/20/2023.

What was the dividend of Isofol Medical AB (publ) in the year 2023?

In the year 2023, Isofol Medical AB (publ) distributed 0 SEK as dividends.

In which currency does Isofol Medical AB (publ) pay out the dividend?

The dividends of Isofol Medical AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Isofol Medical AB (publ)

Our stock analysis for Isofol Medical AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Isofol Medical AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.